An Emerging Global Leader in the New Generation of Anti-Infective Therapies.
Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q) are pioneering a new class of synthetic anti-infectives to address the urgent global health threat posed by superbugs
Recce’s anti-infectives have been designed with a unique mechanism of action, with the goal of re-empowering physicians with an effective treatment that may be used repeatedly against a broad range of bacteria.
Dr Graham Melrose
Recce Pharmaceuticals was founded by Dr Graham Melrose, a former Executive Director and Head of Research at Johnson & Johnson Asia Pacific and Australia. building upon his early, independent research, Recce Pharmaceuticals was formed.